0 Ask Beta Account

Bromocriptine and premenstrual symptoms: a survey of double blind trials

B Andersch

  • Shanghai East Hospital ROR

Obstetrical & Gynecological Survey, 38(11), 643-646

DOI 10.1097/00006254-198311000-00001 PMID 6358978

Abstract

This is a survey of 14 placebo-controlled studies regarding the treatment of premenstrual symptoms with bromocriptine. There is no substantial support that bromocriptine is an effective drug in the premenstrual syndrome as an entity. Symptoms such as irritability, depression, and anxiety were not significantly improved during treatment with bromocriptine compared to placebo treatment. Bromocriptine appears to be the treatment of choice in premenstrual mastodynia if the dosage of bromocriptine is at least 5 mg daily. Bromocriptine may therefore have a place in selected cases of the premenstrual syndrome with associated mastodynia.

Topics

Menstrual Cycle > Premenstrual Syndrome > Pharmacological TreatmentMenstrual Cycle > Premenstrual Syndrome > MastodyniaResearch Methodology > Systematic Review > Double-Blind Trials
bromocriptine premenstrual syndrome double blind trial survey, bromocriptine premenstrual mastodynia treatment, PMS bromocriptine placebo controlled trial meta-analysis, premenstrual breast pain dopamine agonist treatment, bromocriptine irritability depression anxiety premenstrual, Andersch bromocriptine premenstrual symptoms review, prolactin inhibition premenstrual syndrome treatment, bromocriptine 5 mg daily premenstrual mastodynia efficacy, premenstrual syndrome pharmacological treatment placebo comparison, cyclic mastalgia bromocriptine dopamine agonist
PMID 6358978 6358978 DOI 10.1097/00006254-198311000-00001 10.1097/00006254-198311000-00001

Cite this article

Andersch, B. (1983). Bromocriptine and premenstrual symptoms: a survey of double blind trials. *Obstetrical & gynecological survey*, *38*(11), 643-646. https://doi.org/10.1097/00006254-198311000-00001

Keywords

Adult, Bromocriptine/therapeutic Use, Clinical Trials As Topic, Double-Blind Method, Female, Humans, Premenstrual Syndrome/diagnosis/drug Therapy, Bromocriptine

Related articles

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review
Dimmock PW et al., 2000 Lancet (London, England)

BACKGROUND: Selective serotonin-reuptake inhibitors (SSRIs) are increasingly being used as first-line therapy for severe premenstrual syndrome (PMS). We undertook a meta-analysis on the efficacy of SS...

Menstrual Cycle > Premenstrual Syndrome > Pharmacological TreatmentMenstrual Cycle > Premenstrual Syndrome > SSRI TherapyResearch Methodology > Systematic Review > Meta-Analysis

A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome
Freeman EW et al., 1995 JAMA

OBJECTIVE: To determine the effectiveness of oral micronized progesterone, alprazolam, and placebo in premenstrual syndrome (PMS) treatment and the effect of clinical contact on treatment responses. ...

Menstrual Cycle > Premenstrual Syndrome > Pharmacological TreatmentReproductive Endocrinology > Progesterone > PMS Treatment EfficacyResearch Methodology > Randomized Controlled Trials > PMS Interventions

Clinical trial of naltrexone in premenstrual syndrome
Chuong CJ et al., 1988 Obstetrics and Gynecology

Twenty women with the diagnosis of premenstrual syndrome (PMS) participated in a double-blind, placebo-controlled, crossover study to evaluate the efficacy of naltrexone, an oral opiate antagonist. Th...

Menstrual Cycle > Premenstrual Syndrome > Pharmacological TreatmentMenstrual Cycle > Premenstrual Syndrome > Opioid SystemResearch Methodology > Clinical Trials > Crossover Design

Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial
Smith S et al., 1987 Obstetrics and Gynecology

A double-blind, placebo-controlled, randomized multiple crossover study was designed to determine the effectiveness of alprazolam in the treatment of premenstrual syndrome. Patients maintained daily d...

Menstrual Cycle > Premenstrual Syndrome > Pharmacological TreatmentResearch Methodology > Clinical Trials > Randomized Crossover DesignMenstrual Cycle > Premenstrual Syndrome > Anxiolytic Therapy